Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$55.39
+2.4%
$57.65
$25.36
▼
$66.02
$2.82B1.23864,797 shs723,006 shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$5.39
-7.9%
$7.56
$2.33
▼
$10.21
$1.44B2.166.23 million shs4.11 million shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$69.14
-0.7%
$65.72
$53.16
▼
$97.59
$2.06B1.03511,611 shs464,236 shs
InMode Ltd. stock logo
INMD
InMode
$12.42
-2.2%
$13.94
$12.40
▼
$16.67
$713.90M1.98781,943 shs706,987 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-2.42%-3.34%-6.17%+10.47%+58.31%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-3.94%-12.46%-19.84%-38.37%+143.45%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-1.68%+1.44%+13.98%-4.21%+4.14%
InMode Ltd. stock logo
INMD
InMode
-1.40%-3.71%-10.18%-15.67%-9.61%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$55.39
+2.4%
$57.65
$25.36
▼
$66.02
$2.82B1.23864,797 shs723,006 shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$5.39
-7.9%
$7.56
$2.33
▼
$10.21
$1.44B2.166.23 million shs4.11 million shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$69.14
-0.7%
$65.72
$53.16
▼
$97.59
$2.06B1.03511,611 shs464,236 shs
InMode Ltd. stock logo
INMD
InMode
$12.42
-2.2%
$13.94
$12.40
▼
$16.67
$713.90M1.98781,943 shs706,987 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-2.42%-3.34%-6.17%+10.47%+58.31%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-3.94%-12.46%-19.84%-38.37%+143.45%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-1.68%+1.44%+13.98%-4.21%+4.14%
InMode Ltd. stock logo
INMD
InMode
-1.40%-3.71%-10.18%-15.67%-9.61%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.58
Moderate Buy$62.3012.11% Upside
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.75
Moderate Buy$8.7561.17% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.80
Moderate Buy$95.0038.43% Upside
InMode Ltd. stock logo
INMD
InMode
2.00
Hold$16.3331.24% Upside

Current Analyst Ratings Breakdown

Latest INMD, ATRC, ESTA, and BFLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
InMode Ltd. stock logo
INMD
InMode
UpgradeSell (D) ➝ Sell (D+)
11/12/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Set Price Target$70.00
11/12/2026
InMode Ltd. stock logo
INMD
InMode
Lower Price TargetNeutral$17.00 ➝ $15.00
11/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetBuy$63.00 ➝ $70.00
11/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
UpgradeHold ➝ Strong-Buy
11/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetBuy$55.00 ➝ $67.00
11/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetNeutral$36.00 ➝ $62.00
11/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Reiterated RatingOverweight$60.00 ➝ $70.00
11/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetBuy$64.00 ➝ $70.00
11/2/2026
InMode Ltd. stock logo
INMD
InMode
DowngradeSell (D+) ➝ Sell (D)
10/30/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Reiterated RatingSell (D-)
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M5.29$0.31 per share177.16$10.47 per share5.31
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$97.61M14.88N/AN/A$0.69 per share7.87
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$211.08M9.70N/AN/A$0.52 per share131.97
InMode Ltd. stock logo
INMD
InMode
$370.49M1.93$1.44 per share8.63$11.33 per share1.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M$0.30185.32111.14N/A2.52%4.01%3.03%N/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$77.06M-$0.21N/AN/AN/A-43.56%-21.60%-14.25%N/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$51.06M-$1.28N/AN/AN/A-14.56%-196.38%-10.45%N/A
InMode Ltd. stock logo
INMD
InMode
$93.83M$1.2110.29N/AN/A19.94%11.55%10.18%N/A

Latest INMD, ATRC, ESTA, and BFLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/11/2026Q3 2026
InMode Ltd. stock logo
INMD
InMode
$0.3214$0.37+$0.0486$0.32$91.58 million$92.14 million
11/3/2026Q3 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.0552$0.17+$0.2252$0.08$151.05 million$154.45 million
10/30/2026Q3 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.2568-$0.35-$0.0932-$0.35$66.81 million$71.99 million
10/29/2026Q3 2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.0353-$0.01+$0.0253-$0.05$28.37 million$32.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.17
4.33
3.29
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
3.58
2.71
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
17.17
3.57
2.38
InMode Ltd. stock logo
INMD
InMode
N/A
8.58
7.28

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
InMode Ltd. stock logo
INMD
InMode
68.04%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
21.99%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
9.99%
InMode Ltd. stock logo
INMD
InMode
6.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,35050.92 million48.89 millionOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
220267.46 million208.65 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,00429.82 million26.84 millionOptionable
InMode Ltd. stock logo
INMD
InMode
66057.48 million53.50 millionOptionable

Recent News About These Companies

InMode (NASDAQ:INMD) Hits New 12-Month Low - Here's Why
Head to Head Review: InMode (INMD) versus The Competition
Canaccord Genuity Keeps Their Hold Rating on InMode (INMD)
InMode Reports Third-Quarter 2026 Revenue of $92.1 Million
InMode (NASDAQ:INMD) Stock Price Target Lowered at Robert W. Baird
Inmode Q3 Income Declines
InMode expects $92 million Q3 revenue

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AtriCure stock logo

AtriCure NASDAQ:ATRC

$55.39 +1.28 (+2.37%)
Closing price 04:00 PM Eastern
Extended Trading
$55.42 +0.03 (+0.06%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$5.39 -0.46 (-7.86%)
Closing price 03:59 PM Eastern
Extended Trading
$5.51 +0.12 (+2.15%)
As of 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$69.14 -0.47 (-0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$69.12 -0.02 (-0.03%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

InMode stock logo

InMode NASDAQ:INMD

$12.42 -0.28 (-2.20%)
Closing price 03:59 PM Eastern
Extended Trading
$12.42 +0.01 (+0.04%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.